🇺🇸 FDA
Pipeline program

Linaclotide

MCP-103-305

Approved small_molecule completed

Quick answer

Linaclotide for Irritable Bowel Syndrome With Constipation is a Approved program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 3 ClinicalTrials.gov record(s).

Program details

Company
IRONWOOD PHARMACEUTICALS INC
Indication
Irritable Bowel Syndrome With Constipation
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials